196 related articles for article (PubMed ID: 25538239)
1. Dimeric quaternary structure of human laforin.
Sankhala RS; Koksal AC; Ho L; Nitschke F; Minassian BA; Cingolani G
J Biol Chem; 2015 Feb; 290(8):4552-4559. PubMed ID: 25538239
[TBL] [Abstract][Full Text] [Related]
2. Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease.
Raththagala M; Brewer MK; Parker MW; Sherwood AR; Wong BK; Hsu S; Bridges TM; Paasch BC; Hellman LM; Husodo S; Meekins DA; Taylor AO; Turner BD; Auger KD; Dukhande VV; Chakravarthy S; Sanz P; Woods VL; Li S; Vander Kooi CW; Gentry MS
Mol Cell; 2015 Jan; 57(2):261-72. PubMed ID: 25544560
[TBL] [Abstract][Full Text] [Related]
3. Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity.
Dukhande VV; Rogers DM; Romá-Mateo C; Donderis J; Marina A; Taylor AO; Sanz P; Gentry MS
PLoS One; 2011; 6(8):e24040. PubMed ID: 21887368
[TBL] [Abstract][Full Text] [Related]
4. Biophysical characterization of laforin-carbohydrate interaction.
Dias DM; Furtado J; Wasielewski E; Cruz R; Costello B; Cole L; Faria TQ; Baaske P; Brito RM; Ciulli A; Simões I; Macedo-Ribeiro S; Faro C; Geraldes CF; Castanheira P
Biochem J; 2016 Feb; 473(3):335-45. PubMed ID: 26578817
[TBL] [Abstract][Full Text] [Related]
5. The unique evolution of the carbohydrate-binding module CBM20 in laforin.
Kuchtová A; Gentry MS; Janeček Š
FEBS Lett; 2018 Feb; 592(4):586-598. PubMed ID: 29389008
[TBL] [Abstract][Full Text] [Related]
6. Dimerization of the glucan phosphatase laforin requires the participation of cysteine 329.
Sánchez-Martín P; Raththagala M; Bridges TM; Husodo S; Gentry MS; Sanz P; Romá-Mateo C
PLoS One; 2013; 8(7):e69523. PubMed ID: 23922729
[TBL] [Abstract][Full Text] [Related]
7. Laforin, a dual-specificity phosphatase involved in Lafora disease, is phosphorylated at Ser25 by AMP-activated protein kinase.
Romá-Mateo C; Solaz-Fuster Mdel C; Gimeno-Alcañiz JV; Dukhande VV; Donderis J; Worby CA; Marina A; Criado O; Koller A; Rodriguez De Cordoba S; Gentry MS; Sanz P
Biochem J; 2011 Oct; 439(2):265-75. PubMed ID: 21728993
[TBL] [Abstract][Full Text] [Related]
8. A bioassay for Lafora disease and laforin glucan phosphatase activity.
Sherwood AR; Johnson MB; Delgado-Escueta AV; Gentry MS
Clin Biochem; 2013 Dec; 46(18):1869-76. PubMed ID: 24012855
[TBL] [Abstract][Full Text] [Related]
9. Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii.
Gentry MS; Romá-Mateo C; Sanz P
FEBS J; 2013 Jan; 280(2):525-37. PubMed ID: 22364389
[TBL] [Abstract][Full Text] [Related]
10. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.
Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S
Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330
[TBL] [Abstract][Full Text] [Related]
11. Expression, purification and characterization of soluble red rooster laforin as a fusion protein in Escherichia coli.
Brewer MK; Husodo S; Dukhande VV; Johnson MB; Gentry MS
BMC Biochem; 2014 Apr; 15():8. PubMed ID: 24690255
[TBL] [Abstract][Full Text] [Related]
12. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.
Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S
Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386
[TBL] [Abstract][Full Text] [Related]
13. Exploring the structural insights on human laforin mutation K87A in Lafora disease--a molecular dynamics study.
Srikumar PS; Rohini K
Appl Biochem Biotechnol; 2013 Oct; 171(4):874-82. PubMed ID: 23904258
[TBL] [Abstract][Full Text] [Related]
14. Assessing the Biological Activity of the Glucan Phosphatase Laforin.
Romá-Mateo C; Raththagala M; Gentry MS; Sanz P
Methods Mol Biol; 2016; 1447():107-19. PubMed ID: 27514803
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of a laforin nanobody inhibitor.
Simmons ZR; Sharma S; Wayne J; Li S; Vander Kooi CW; Gentry MS
Clin Biochem; 2021 Jul; 93():80-89. PubMed ID: 33831386
[TBL] [Abstract][Full Text] [Related]
16. Conservation of the glucan phosphatase laforin is linked to rates of molecular evolution and the glucan metabolism of the organism.
Gentry MS; Pace RM
BMC Evol Biol; 2009 Jun; 9():138. PubMed ID: 19545434
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Insights into Glucan Phosphatase Activity against Polyglucan Substrates.
Meekins DA; Raththagala M; Auger KD; Turner BD; Santelia D; Kötting O; Gentry MS; Vander Kooi CW
J Biol Chem; 2015 Sep; 290(38):23361-70. PubMed ID: 26231210
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease.
Sanchez-Martin P; Lahuerta M; Viana R; Knecht E; Sanz P
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118613. PubMed ID: 31758957
[TBL] [Abstract][Full Text] [Related]
19. Muscle glycogen remodeling and glycogen phosphate metabolism following exhaustive exercise of wild type and laforin knockout mice.
Irimia JM; Tagliabracci VS; Meyer CM; Segvich DM; DePaoli-Roach AA; Roach PJ
J Biol Chem; 2015 Sep; 290(37):22686-98. PubMed ID: 26216881
[TBL] [Abstract][Full Text] [Related]
20. Are there errors in glycogen biosynthesis and is laforin a repair enzyme?
Roach PJ
FEBS Lett; 2011 Oct; 585(20):3216-8. PubMed ID: 21930129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
